Detalhe da pesquisa
1.
Enhancing Antibody-Specific Productivity: Unraveling the Impact of XBP1s Overexpression and Glutamine Availability in SP2/0 Cells.
Bioengineering (Basel)
; 11(3)2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534475
2.
89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model.
Mol Cancer Ther
; 21(4): 607-615, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086952
3.
Role of complement in protection against Cryptococcus gattii infection.
Infect Immun
; 77(3): 1061-70, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19114546
4.
An HK2 Antisense Oligonucleotide Induces Synthetic Lethality in HK1-HK2+ Multiple Myeloma.
Cancer Res
; 79(10): 2748-2760, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885978
5.
Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha.
J Interferon Cytokine Res
; 38(6): 239-254, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29920129
6.
Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma.
MAbs
; 8(7): 1386-1397, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27362935
7.
Anti-CD138-targeted interferon is a potent therapeutic against multiple myeloma.
J Interferon Cytokine Res
; 35(4): 281-91, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25353626
8.
Anti-CD20-interferon-ß fusion protein therapy of murine B-cell lymphomas.
J Immunother
; 36(5): 305-18, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23719241
9.
In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.
Mol Immunol
; 48(15-16): 2009-18, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21723612